Patrick Soon-Shiong Net Worth Overview
Dr Patrick Soon-Shiong is a South African-American billionaire businessman, surgeon, and investor known for controlling major media and pharmaceutical companies. His estimated net worth is based on holdings in NantHealth, NantKwest, Tribune Publishing, the Los Angeles Times, and other private and public assets. Public sources and financial profiles list his fortune in the low billions, reflecting equity stakes, company valuations, and real estate interests. For background on his career and corporate roles, see the overview at Forbes profile.
The core of Dr Patrick Soon-Shiong net worth comes from his stakes in NantWorks, the parent entity for NantHealth, NantKwest, and related healthcare technology ventures. NantHealth went public in 2021 on NASDAQ under the ticker NKH, and NantKwest merged with a SPAC to trade as NKWA before being taken private again. Valuations of these companies, combined with his ownership percentages, form the bulk of his reported wealth. Additional value comes from real estate, private equity investments, and stakes in media properties such as the Los Angeles Times.
Major Companies and Business Holdings
NantWorks is the central holding company through which Dr Soon-Shiong controls a portfolio of healthcare, technology, and media businesses. NantHealth provides cloud-based healthcare IT solutions and claims data platforms used by hospitals and insurers across the United States. NantKwest focused on immunotherapy and oncology drug development before its merger and subsequent restructuring. These companies are tracked by the SEC through public filings, which provide insight into corporate structure and ownership. See the SEC EDGAR filings for NantHealth at SEC EDGAR for NantHealth.
Dr Soon-Shiong acquired the Los Angeles Times and other Tribune Publishing newspapers in 2018, adding a major media asset to his portfolio. Tribune Publishing operates daily newspapers in several major U.S. cities, and the acquisition was structured through shell companies and investment vehicles. The deal was widely reported as a significant use of his personal capital and is frequently cited in net worth estimates. The transaction details are covered by The New York Times.
NantHealth and Healthcare Technology
NantHealth operates the Evident platform, which aggregates clinical and financial data for healthcare providers and payers. The company has partnerships with major health systems and technology firms, and its public filings show revenue growth and client expansion. NantHealth's market capitalization at the time of its IPO contributed to Dr Soon-Shiong's net worth through his retained equity position. The platform is used for population health management, claims analytics, and interoperability solutions across hospital networks.
NantKwest and Immunotherapy Pipeline
NantKwest developed targeted immunotherapies, including therapies based on natural killer cells and tumor-infiltrating lymphocytes. The company advanced multiple clinical trials in oncology before merging with a SPAC and later restructuring its pipeline. The evolution of NantKwest's assets and partnerships is documented in SEC filings and press releases, which are used in financial analyses of Dr Soon-Shiong's holdings.
Wealth Sources and Asset Breakdown
The primary drivers of Dr Patrick Soon-Shiong net worth are his equity stakes in NantWorks companies, real estate holdings, and private investments. NantHealth and related entities are valued based on public market